Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Evaluation of progesterone permeability from supercritical fluid processed dispersion systems.

Falconer JR, Wen J, Zargar-Shoshtari S, Chen JJ, Farid M, El Maghraby GM, Alany RG.

Pharm Dev Technol. 2014 Mar;19(2):238-46. doi: 10.3109/10837450.2013.769570. Epub 2013 Feb 25.

PMID:
23432633
2.

Preparation and characterization of progesterone dispersions using supercritical carbon dioxide.

Falconer JR, Wen J, Zargar-Shoshtari S, Chen JJ, Farid M, Tallon SJ, Alany RG.

Drug Dev Ind Pharm. 2014 Apr;40(4):458-69. doi: 10.3109/03639045.2013.768630. Epub 2013 Feb 18.

PMID:
23418960
3.

The effects of supercritical carbon dioxide processing on progesterone dispersion systems: a multivariate study.

Falconer JR, Wen J, Zargar-Shoshtari S, Chen JJ, Mohammed F, Chan J, Alany RG.

AAPS PharmSciTech. 2012 Dec;13(4):1255-65. doi: 10.1208/s12249-012-9850-z. Epub 2012 Sep 20.

4.

In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.

Gannu R, Vishnu YV, Kishan V, Rao YM.

PDA J Pharm Sci Technol. 2008 Jul-Aug;62(4):256-63.

PMID:
19174954
5.

Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.

Eedara BB, Veerareddy PR, Jukanti R, Bandari S.

Drug Dev Ind Pharm. 2014 Aug;40(8):1030-43. doi: 10.3109/03639045.2013.801984. Epub 2013 Jun 5.

PMID:
23738504
6.
7.

Design and characterization of submicron formulation for a poorly soluble drug: the effect of Vitamin E TPGS and other solubilizers on skin permeability enhancement.

Ghosh I, Michniak-Kohn B.

Int J Pharm. 2012 Sep 15;434(1-2):90-8. doi: 10.1016/j.ijpharm.2012.05.031. Epub 2012 May 23.

PMID:
22633930
8.
9.
11.
12.

Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.

Ge S, Lin Y, Lu H, Li Q, He J, Chen B, Wu C, Xu Y.

Int J Pharm. 2014 Apr 25;465(1-2):120-31. doi: 10.1016/j.ijpharm.2014.02.012. Epub 2014 Feb 12.

PMID:
24530389
14.

Tabletability assessment of conventional formulations containing Vitamin E tocopheryl polyethylene glycol succinate.

Jin F, Tatavarti A.

Int J Pharm. 2010 Apr 15;389(1-2):58-65. doi: 10.1016/j.ijpharm.2010.01.017. Epub 2010 Jan 18.

PMID:
20083178
15.

Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.

Moneghini M, De Zordi N, Solinas D, Macchiavelli S, Princivalle F.

Future Med Chem. 2010 Feb;2(2):237-46. doi: 10.4155/fmc.09.166.

PMID:
21426191
16.

The applications of Vitamin E TPGS in drug delivery.

Guo Y, Luo J, Tan S, Otieno BO, Zhang Z.

Eur J Pharm Sci. 2013 May 13;49(2):175-86. doi: 10.1016/j.ejps.2013.02.006. Epub 2013 Feb 26. Review.

PMID:
23485439
17.

Processing challenges with solid dosage formulations containing vitamin E TPGS.

Pandey P, Sinko PD, Bindra DS, Hamey R, Gour S, Vema-Varapu C.

Pharm Dev Technol. 2013 Feb;18(1):296-304. doi: 10.3109/10837450.2012.737807. Epub 2012 Nov 9.

PMID:
23136832
18.

Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.

Gannu R, Vishnu YV, Kishan V, Rao YM.

Curr Drug Deliv. 2007 Jan;4(1):69-76.

PMID:
17269919
19.

Development of novel formulations to enhance in vivo transdermal permeation of tocopherol.

Nada AH, Zaghloul AA, Hedaya MM, Khattab IS.

Acta Pharm. 2014 Sep;64(3):299-309. doi: 10.2478/acph-2014-0021.

PMID:
25296676
20.

Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion.

Repka MA, McGinity JW.

Int J Pharm. 2000 Jul 20;202(1-2):63-70.

PMID:
10915927

Supplemental Content

Support Center